drugset
Drugs / bacille Calmette-Guérin
last change Feb 2018 re-read 2 minutes ago

bacille Calmette-Guérin

also known as BCG · BCG Vaccine SSI

Vaccine

Developed for
tuberculosis
Investigated by
Department for International Development, United Kingdom · Mark Hatherill · Medical Research Council · Oxford-Emergent Tuberculosis Consortium · University of Oxford · University of Stellenbosch
+1 more · Wellcome Trust

Trials 1 · a red edge is where a trial was stopped

today NCT01650389 · Ph 2
201320142015201620172018201920202021202220232024202520262027
PhaseRegistry idDatesIndicationSponsorStatusOutcome
Phase 2 NCT01650389 Oct 2012 → May 2015 HIV infectious disease, tuberculosis Mark Hatherill Completed No outcome recorded

Evidence & citations 4 cited values

Every value below carries the sentence it was read from. 2 sources stand behind the page.

FieldValueCited text
Known as bacille Calmette-Guérin “Vaccination of human immunodeficiency virus (HIV)-infected infants with bacille Calmette-Guérin (BCG) is contraindicated.” PMID 29028973 ↗ Feb 2018
Known as BCG ClinicalTrials.gov intervention name — accepted as the source's own label NCT01650389 ↗
Known as BCG Vaccine SSI “Infants confirmed HIV uninfected by HIV PCR will receive BCG Vaccine SSI at 8 weeks of age.” NCT01650389 ↗
Modality Vaccine “The Bacille Calmette-Guérin (BCG) vaccine protects children against disseminated tuberculosis (TB) including TB meningitis and miliary TB” NCT01650389 ↗